Aldosterone Antagonism as an Antiarrhythmic Approach for Atrial Arrhythmias in Heart Failure
暂无分享,去创建一个
[1] B. Hoit,et al. Selective Aldosterone Blockade Suppresses Atrial Tachyarrhythmias in Heart Failure , 2006, Journal of cardiovascular electrophysiology.
[2] H. Inoue,et al. Enalapril Preserves Sinus Node Function in a Canine Atrial Fibrillation Model Induced by Rapid Atrial Pacing , 2005, Journal of cardiovascular electrophysiology.
[3] E. Vicaut,et al. Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction. , 2005, European heart journal.
[4] Harlan M Krumholz,et al. ACC/AHA Clinical Performance Measures for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society , 2005, Circulation.
[5] C. Boos,et al. Targeting the renin–angiotensin–aldosterone system in atrial fibrillation: from pathophysiology to clinical trials , 2005, Journal of Human Hypertension.
[6] D. Goldspink,et al. Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivo. , 2005, Journal of molecular and cellular cardiology.
[7] Stanley Nattel,et al. Atrial Ionic Remodeling Induced by Atrial Tachycardia in the Presence of Congestive Heart Failure , 2004, Circulation.
[8] S. Nattel,et al. Dissociation Between Ionic Remodeling and Ability to Sustain Atrial Fibrillation During Recovery From Experimental Congestive Heart Failure , 2004, Circulation.
[9] C. Guiraudon,et al. Characterization of Sustained Atrial Tachycardia in Dogs with Rapid Ventricular Pacing‐Induced Heart Failure , 2003, Journal of cardiovascular electrophysiology.
[10] S. Nattel,et al. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. , 2002, Cardiovascular research.
[11] A. Goette,et al. Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation. , 2001, The American journal of cardiology.
[12] F. Alla,et al. Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure: Insights From the Randomized Aldactone Evaluation Study (RALES) , 2000, Circulation.
[13] A. Goette,et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. , 2000, Journal of the American College of Cardiology.
[14] L. Køber,et al. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. , 1999, Circulation.
[15] S Nattel,et al. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. , 1999, Circulation.
[16] S. Lévy. Epidemiology and classification of atrial fibrillation. , 1998, Journal of cardiovascular electrophysiology.